External validation of PREDICT Breast v3.1 for overall survival in international cohorts, including young and invasive lobular subgroups.
Saved in:
| Title: | External validation of PREDICT Breast v3.1 for overall survival in international cohorts, including young and invasive lobular subgroups. |
|---|---|
| Authors: | Verheul EM; Center for Medical Decision Making, Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. e.verheul@erasmusmc.nl.; Dutch Institute for Clinical Auditing, Leiden, The Netherlands. e.verheul@erasmusmc.nl., Doornkamp F; Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Petrov I; Microbiology, Tumour- and Cell Biology Department, Karolinska Institutet, Stockholm, Sweden.; Cancer Centrum Karolinska (CCK), Solna, Sweden., Siesling S; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Lingsma HF; Center for Medical Decision Making, Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands., Koppert LB; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Vreven LWA; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Karsten MM; Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Berlin, Germany., Doppelbauer L; Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Berlin, Germany., Gebert P; Berlin Institute of Health at Charité -Universitätsmedizin Berlin, Berlin, Germany.; Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Kiani N; Department of Oncology-Pathology, Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.; Algorithmic Dynamics Lab, Karolinska Institutet, Solna, Sweden., Borstnar S; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Pharoah PDP; Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hedayati E; Department of Oncology-Pathology, Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.; Breast Cancer Centre, Cancer Theme, Karolinska University Hospital, Karolinska CCC, Stockholm, Sweden., Steyerberg EW; Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands., van Klaveren D; Center for Medical Decision Making, Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. |
| Corporate Authors: | 4D PICTURE Consortium |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2026 Apr 17; Vol. 217 (2). Date of Electronic Publication: 2026 Apr 17. |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41991871 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: External validation of PREDICT Breast v3.1 for overall survival in international cohorts, including young and invasive lobular subgroups. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Verheul+EM%22">Verheul EM</searchLink>; Center for Medical Decision Making, Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. e.verheul@erasmusmc.nl.; Dutch Institute for Clinical Auditing, Leiden, The Netherlands. e.verheul@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Doornkamp+F%22">Doornkamp F</searchLink>; Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Petrov+I%22">Petrov I</searchLink>; Microbiology, Tumour- and Cell Biology Department, Karolinska Institutet, Stockholm, Sweden.; Cancer Centrum Karolinska (CCK), Solna, Sweden.<br /><searchLink fieldCode="AU" term="%22Siesling+S%22">Siesling S</searchLink>; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lingsma+HF%22">Lingsma HF</searchLink>; Center for Medical Decision Making, Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Koppert+LB%22">Koppert LB</searchLink>; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vreven+LWA%22">Vreven LWA</searchLink>; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Voogd+AC%22">Voogd AC</searchLink>; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Karsten+MM%22">Karsten MM</searchLink>; Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Doppelbauer+L%22">Doppelbauer L</searchLink>; Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Gebert+P%22">Gebert P</searchLink>; Berlin Institute of Health at Charité -Universitätsmedizin Berlin, Berlin, Germany.; Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kiani+N%22">Kiani N</searchLink>; Department of Oncology-Pathology, Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.; Algorithmic Dynamics Lab, Karolinska Institutet, Solna, Sweden.<br /><searchLink fieldCode="AU" term="%22Borstnar+S%22">Borstnar S</searchLink>; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Pharoah+PDP%22">Pharoah PDP</searchLink>; Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hedayati+E%22">Hedayati E</searchLink>; Department of Oncology-Pathology, Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.; Breast Cancer Centre, Cancer Theme, Karolinska University Hospital, Karolinska CCC, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Steyerberg+EW%22">Steyerberg EW</searchLink>; Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Klaveren+D%22">van Klaveren D</searchLink>; Center for Medical Decision Making, Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%224D+PICTURE+Consortium%22">4D PICTURE Consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2026 Apr 17; Vol. 217 (2). <i>Date of Electronic Publication: </i>2026 Apr 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Validation Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41991871 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10549-026-07958-w Languages: – Code: eng Text: English Titles: – TitleFull: External validation of PREDICT Breast v3.1 for overall survival in international cohorts, including young and invasive lobular subgroups. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Verheul EM – PersonEntity: Name: NameFull: Doornkamp F – PersonEntity: Name: NameFull: Petrov I – PersonEntity: Name: NameFull: Siesling S – PersonEntity: Name: NameFull: Lingsma HF – PersonEntity: Name: NameFull: Koppert LB – PersonEntity: Name: NameFull: Vreven LWA – PersonEntity: Name: NameFull: Voogd AC – PersonEntity: Name: NameFull: Karsten MM – PersonEntity: Name: NameFull: Doppelbauer L – PersonEntity: Name: NameFull: Gebert P – PersonEntity: Name: NameFull: Kiani N – PersonEntity: Name: NameFull: Borstnar S – PersonEntity: Name: NameFull: Pharoah PDP – PersonEntity: Name: NameFull: Hedayati E – PersonEntity: Name: NameFull: Steyerberg EW – PersonEntity: Name: NameFull: van Klaveren D IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 04 Text: 2026 Apr 17 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1573-7217 Numbering: – Type: volume Value: 217 – Type: issue Value: 2 Titles: – TitleFull: Breast cancer research and treatment Type: main |
| ResultId | 1 |